Safety and Efficacy of BA1302 in Patients With Advanced Solid Tumors

Clinical trial NCT06596915 · RECRUITING

Trial details

NCT number: NCT06596915
Sponsor: Shandong Boan Biotechnology Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer Pancreatic Adenocarcinoma Breast Cancer Melanoma

Start date: 2024-09-11
Primary completion: 2025-12-31
Enrollment: 167

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.